M&A Deal Summary

Novotech Acquires EastHORN

On January 10, 2023, Novotech acquired life science company EastHORN

Acquisition Highlights
  • This is Novotech’s 2nd transaction in the Life Science sector.
  • This is Novotech’s 1st transaction in Poland.

M&A Deal Summary

Date 2023-01-10
Target EastHORN
Sector Life Science
Buyer(s) Novotech
Deal Type Add-on Acquisition

Target

EastHORN

Warsaw, Poland
EastHORN provides CRO with clinical, medical, and regulatory expertise in multiple strategically important locations across the continent. EastHORN was founded in 2004 and is based in Warsaw, Poland.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Novotech

Sydney, Australia

Category Company
Founded 1997
Sector Life Science
DESCRIPTION

Novotech is a full-service contract research organization (CRO) that provides biotech and small- to mid-sized pharmaceutical companies. Novotech was founded in 1997 and is headquartered in Sydney, New South Wales.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Poland M&A 1 of 1
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-10 CBR International

Boulder, Colorado, United States

CBR International is a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from early-stage development through to approval. CBR International was founded in 2002 and is based in Boulder, Colorado.

Buy -